REDMOND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions®, Inc. today announced the first implant of the CARILLON™ Mitral Contour System™ as part of its new TITAN™ study. The procedure was performed in Neuss Germany by Professor Dr. med. Michael Haude. TITAN™ is the latest clinical effort initiated by Cardiac Dimensions®. The study, which will be conducted in 6 centers across Europe and enroll up to 50 patients, will assess safety and efficacy at 1, 6, 12, 18, and 24 months, then annually at 3, 4, and 5 years.
